An analysis of institutional effects in a multicenter cancer clinical trial: Is it also plausible from the clinicians' point of view?

Japanese Journal of Clinical Oncology

Volumn 29, Issue 8, 1999, Pages 403-405

  Sakamoto, Junichi ^a   Matsuyama, Yutaka ^b   Ohashi, Yasuo ^b  

^a AICHI PREFECTURAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CENTER; CLINICAL TRIAL; HUMAN; MULTICENTER STUDY; NEOPLASM; ONCOLOGY; STANDARD; STATISTICS;

CANCER CARE FACILITIES; CLINICAL TRIALS; HUMANS; MEDICAL ONCOLOGY; MULTICENTER STUDIES; NEOPLASMS;

EID: 0033176554     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.8.403     Document Type: Article

References (3)

1. Matsuyama Y, Sakamoto J, Ohashi Y. A Bayesian hierarchial survival model for the institutional effects in a multicenter cancer clinical trial. Stat Med 1998;17:1893-908.
2. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 1994;343:1122-6.
3. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. London: Chapman and Hall 1995;320-44.